Qixingxingchen (002439): Cash flow significantly improves the industry’s high income under the boom

Qixingxingchen (002439): Cash flow significantly improves the industry’s high income under the boom Event company released the first quarter of 2019 report, the first quarter of 2019 revenue3. 50,000 yuan, an increase of 18 in ten years. 6%; net profit attributable to the parent in the first quarter of 2019 was -4051. 10,000 yuan, 1632 … Read moreQixingxingchen (002439): Cash flow significantly improves the industry’s high income under the boom

Dongfeng (601515): Steady growth of the main business meets expectations

Dongfeng (601515): Steady growth of the main business meets expectations The company achieved revenue 9 in the first quarter of 2019. 07 million yuan, an increase of 11 in ten years. 47%; net profit attributable to mother 2. 20 ppm, an increase of 5 in ten years. 79%; net profit after deduction to mother 2. … Read moreDongfeng (601515): Steady growth of the main business meets expectations

SAIC Group (600104): Joint venture brand performance is stable, waiting for sales growth to recover

SAIC Group (600104): Joint venture brand performance is stable, waiting for sales growth to recover Event: The company released June production and sales data. The company produced 46 cars in June 2019. 50,000 vehicles, an increase of -16 in ten years. 1% sold 46 cars. 70,000 vehicles, an increase of -15 in ten years. 97%; … Read moreSAIC Group (600104): Joint venture brand performance is stable, waiting for sales growth to recover

Hisun Pharmaceutical (600267): Hisense vPro’s war-to-dating program has initially landed, opening up a new situation for the company’s development

Hisun Pharmaceutical (600267): Hisense vPro’s war-to-dating program has initially landed, opening up a new situation for the company’s development Event: The company announced that, as of September 3, the Hisense Borui old stock transfer / capital expansion and listing period has ended, and a qualified intent assignee, PAG Highlander (Hong Kong) Co., Ltd., has been … Read moreHisun Pharmaceutical (600267): Hisense vPro’s war-to-dating program has initially landed, opening up a new situation for the company’s development

Institutions gather to research technology stocks-post epidemic-the sector receives attention

Institutions gather to study “post-epidemic” section of technology stocks For stocks, please read Jin Qilin analyst research report, authoritative, professional, timely, and comprehensive, to help you tap potential potential opportunities!   Institutions gathered to research technology stocks, and the “post-epidemic” section attracted attention! This inverter star is rising, Huawei is its main rival!   Source: e-manager, Micro-original … Read moreInstitutions gather to research technology stocks-post epidemic-the sector receives attention

Dali Science and Technology (002214) Quick Review of Major Events: Military Infrared Technology Helps to Resist the Epidemic

Dali Science and Technology (002214) Quick Review of Major Events: Military Infrared Technology Helps to Resist the Epidemic Matters: The Ministry of Industry and Information Technology of the People’s Republic of China issued a news saying that on January 29th, the Electronic Information Department of the Ministry of Industry and Information Technology organized 3 automatic … Read moreDali Science and Technology (002214) Quick Review of Major Events: Military Infrared Technology Helps to Resist the Epidemic

China Public Education (002607) 2019 Semi-annual Report Review: Performance Expectations Market Expected Profitability Continues to Improve

China Public Education (002607) 2019 Semi-annual Report Review: Performance Expectations Market Expected Profitability Continues to Improve Event: On August 20, 2019, China Education announced the 2019 semi-annual report: total revenue. 3.7 billion (+48. 79%), net profit attributable to mother 4. 9.3 billion (+132. 18%). Opinion: 19H1 income 36. 400 million (+ 49% year-on-year), with a … Read moreChina Public Education (002607) 2019 Semi-annual Report Review: Performance Expectations Market Expected Profitability Continues to Improve

Special Information (000070): Capital Operation Assists Industrial Transformation

Special Information (000070): Capital Operation Assists Industrial Transformation Event: The company released the 2018 annual report, and the company achieved operating income of 57 from January to December 2018. 06 ppm, an increase of 4 over the same period last year. 26%; Net profit attributable to shareholders of listed companies. 760,000 yuan, an increase of … Read moreSpecial Information (000070): Capital Operation Assists Industrial Transformation

Antu Bio (603658) Quarterly Review: Magnetic Particle Luminescent Reagents Maintain Rapid Growth, Q3 Slightly Expected

Antu Bio (603658) Quarterly Review: Magnetic Particle Luminescent Reagents Maintain Rapid Growth, Q3 Slightly Expected Investment Highlights: The company released the third quarter report for 2019: the first three quarters achieved 苏州夜网论坛 revenue of 18. 9.4 billion (+39. 22%), to achieve a net profit of 5. 3.8 billion (+30. 87%), net profit after deduction is … Read moreAntu Bio (603658) Quarterly Review: Magnetic Particle Luminescent Reagents Maintain Rapid Growth, Q3 Slightly Expected